Kamada (KMDA) Cash from Investing Activities (2013 - 2026)
Kamada (KMDA) reported Cash from Investing Activities of -$41.2 million for Q1 2026, down 2721.78% on a YoY basis from $1.6 million in Q1 2025, and down 1384.61% quarter-over-quarter from -$2.8 million in Q4 2025.
Kamada (KMDA) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Kamada has reported Cash from Investing Activities for 14 years, with the latest figure at -$41.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 2721.78% year-over-year to -$41.2 million; the trailing twelve-month figure through Mar 2026 stood at -$49.6 million (down 420.92% YoY), and the FY2025 full-year result was -$9.8 million, up 8.39% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$41.2 million, down from -$2.8 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$1093.0 in Q1 2023, with the low at -$41.2 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$4.0 million across 5 years, with a median of -$2.0 million in 2023.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 99.79% — and 2024, when it slumped 245279.69%.
- Kamada's Cash from Investing Activities stood at -$977000.0 in 2022, then plunged by 101.94% to -$2.0 million in 2023, then slumped by 48.2% to -$2.9 million in 2024, then grew by 5.1% to -$2.8 million in 2025, then tumbled by 1384.61% to -$41.2 million in 2026.
- The last three Cash from Investing Activities figures came in at -$41.2 million (Q1 2026), -$2.8 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -41.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.20 Mn |
| Mar 31, 2026 | -41.20 Mn |
| Dec 31, 2025 | -2.78 Mn |
| Dec 31, 2025 | -2.78 Mn |
| Sep 30, 2025 | -3.59 Mn |
| Sep 30, 2025 | -3.59 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Mar 31, 2025 | -1.46 Mn |
| Mar 31, 2025 | -1.46 Mn |
| Dec 31, 2024 | -2.92 Mn |
| Dec 31, 2024 | -2.92 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -3.01 Mn |
| Jun 30, 2024 | -3.01 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -1.97 Mn |
| Dec 31, 2023 | -1.97 Mn |